# US 2024/0226218 A1 · Compositions and methods for treating and preventing a coronavirus infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0226218 A1
- Document ID: US20240226218A1
- Status: Published application
- Kind: A1
- Application number: 17/912,804
- Filed: 2021-03-19
- Published: 2024-07-11
- Earliest claimed: 2020-03-20
- Assignees: Novel Concepts Medical Ltd
- Applicants: Novel Concepts Medical Ltd
- Inventors: Rachel ALKALAY
- Web page: https://patentgrep.com/patent/US20240226218A1

## CPC

- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/166: having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A61K 31/405: Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/22: Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A61K 36/258: Panax (ginseng)
- A61K 36/324: Boswellia, e.g. frankincense
- A61K 36/424: Gynostemma
- A61K 36/534: Mentha (mint)
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/71: Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K 36/738: Rosa (rose)
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 36/85: Verbenaceae (Verbena family)
- A61K 36/88: Liliopsida (monocotyledons)
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K 36/9062: Alpinia, e.g. red ginger or galangal
- A61K 38/4873: {Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H}
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 17/14: for baldness or alopecia
- A61P 31/14: for RNA viruses
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of preventing or treating Coronavirus infection in a subject in need thereof is provided. The method comprising administering to the subject an effective amount of a plant species or genus thereof-derived component selected from the group consisting of a plant part, extract thereof, fraction thereof, active ingredient thereof, synthetic analog thereof, mimetic thereof or combination thereof, wherein the component is capable of ameliorating symptoms of Coronavirus infection and wherein the plant species is selected from the group consisting of Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum and Rhus coriaria Gynostemma petaphyllum, Boswellia sacra and Panax ginseng, or any plant containing tryptophan preventing or treating Coronavirus in the subject.

## Claims

### Claim 1

A method of inhibiting, treating or ameliorating the symptoms of Coronavirus infection in a subject in need thereof, the method comprising administering to the subject an effective amount of a plant species or genus thereof-derived component selected from a plant part, extract thereof, fraction thereof, active ingredient thereof, synthetic analog thereof, mimetic thereof or combination thereof, wherein said component is capable of ameliorating symptoms of Coronavirus infection and wherein said plant species is selected from Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum, Rhus coriaria, Gynostemma petaphyllum, Boswellia sacra and Panax ginseng.

### Claim 2

A vaccine against a Coronavirus infection comprising an effective amount of a plant species or genus thereof-derived component selected from a plant part, extract thereof, fraction thereof, active ingredient thereof, synthetic analog thereof, mimetic thereof or combination thereof, wherein said component is capable of ameliorating symptoms of Coronavirus infection and wherein said plant species is selected from Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum, Rhus coriaria, Gynostemma petaphyllum, Boswellia sacra Panax ginseng, Korean ginseng and American ginseng.

### Claim 3

A pharmaceutical composition comprising an effective amount of a plant species or genus thereof-derived component selected from a plant part, extract thereof, fraction thereof, active ingredient thereof, synthetic analog thereof, mimetic thereof or combination thereof, wherein said component is capable of ameliorating symptoms of Coronavirus infection and wherein said plant species is selected from Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum and Rhus coriaria, Gynostemma petaphyllum, Boswellia sacra Panax ginseng, Korean ginseng and American ginseng.

### Claim 4

(canceled)

### Claim 5

A food supplement comprising a combination of at least 2 of a plant species or genus thereof-derived component selected from a plant part, extract thereof, fraction thereof, active ingredient thereof, synthetic analog thereof, mimetic thereof or combination thereof, wherein said component is capable of ameliorating symptoms of Coronavirus infection and wherein said plant species is selected from Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum and Rhus coriaria, Gynostemma petaphyllum, Boswellia sacra Panax ginseng, Korean ginseng and American ginseng.

### Claim 6 (depends on 1)

The method of claim 1, wherein said Coronavirus is SAR-CoV-2, Middle East respiratory syndrome Coronavirus (MERS-CoV) or severe acute respiratory syndrome Coronavirus (SARS-CoV).

### Claim 7 (depends on 1)

The method of claim 1, wherein said Coronavirus is SAR-CoV-2.

### Claim 8 (depends on 1)

The method of claim 1, wherein said symptoms are selected from fever, chills, coughing, shortness of breath, difficulty in breathing, muscle aches, body aches, vomiting and diarrhea.

### Claim 9 (depends on 1)

The method of claim 1, wherein said component comprises at least 2 components.

### Claim 10 (depends on 5)

The food supplement of claim 5, wherein said component comprises at least 3 components.

### Claim 11 (depends on 5)

The food supplement of claim 5, wherein said component comprises at least 4 components.

### Claim 12 (depends on 5)

The food supplement of claim 5, wherein said component comprises at least 5 components.

### Claim 13 (depends on 5)

The food supplement of claim 5, wherein said component comprises 5-10 components.

### Claim 14 (depends on 1)

The method of claim 1, wherein said component comprises thymoquinone or analog thereof.

### Claim 15 (depends on 1)

The method of claim 1, wherein said component comprises thymol or analog thereof.

### Claim 16 (depends on 1)

The method of claim 1, wherein said component comprises carvacrol or analog thereof.

### Claim 17 (depends on 1)

The method of claim 1, wherein said component comprises bromelain or analog thereof.

### Claim 18 (depends on 1)

The method of claim 1, wherein said component comprises extract of pineapple including bromelain or analog thereof.

### Claim 19 (depends on 1)

The method of claim 1, wherein said component comprises extract of any plant containing tryptophan.

### Claim 20 (depends on 1)

The method of claim 1, wherein said component further comprises “Beduin Tea” comprising Rose Leaves, Micromeria fruticose, Salvia, cymbopgon (Citral,) Aloysia, verbena officinalis, origanum majorana, menthe.

### Claim 21 (depends on 1)

The method of claim 1, wherein said component further comprises “Beduin Tea” comprising Thyme, sage, cardamom, cinnamon, Habuk, Marmaya, and black tea.
